The USPTO recently announced a new Prioritized Examination Pilot Program for COVID-19-related patents. Under this new program, applicants which qualify for small or micro entity status will be entitled to prioritized examination at discounted fees and can receive a final disposition from the USPTO within six months. To qualify for this program, the application must claim a product or process that is subject to FDA approval for use in the prevention and/or treatment of COVID-19.
Read more here.